ARTICLES ON ISCHEMIC HEART DISEASE
Is coronary artery bypass grafting still the best strategy? Final 10-year results of the NOBLE trial in unprotected left main coronary artery disease
Prospective, multicentre, randomised clinical trial comparing the long-term outcomes of percutaneous coronary intervention (PCI) with second-generation drug-eluting stents versus coronary artery bypass grafting (CABG) in patients with significant unprotected left main coronary artery stenosis, with long-term all-cause mortality as the primary outcome.
Hybrid alternative for postinfarction VSR: the SurCOP strategy
Description and outcomes of a hybrid strategy for the management of postinfarction VSR.
Can a simple angle compromise a coronary bypass graft? The importance of geometry in sequential arterial revascularization
This study examines the impact of the angle formed at the sequential anastomosis to a diagonal branch (D-angle) in patients undergoing total arterial coronary revascularization with different graft configurations. Variations in the width of this angle may compromise flow through the distal segment of the graft.
Circulatory support in cardiogenic shock undergoing coronary artery bypass surgery: what is changing?
Retrospective observational study analyzing temporal trends in the use of mechanical circulatory support in patients with acute myocardial infarction complicated by cardiogenic shock undergoing coronary artery bypass grafting, as well as its association with operative mortality.
Revascularization using three in situ arterial grafts. Is this a durable strategy in OPCAB?
This retrospective study evaluates long-term outcomes in patients undergoing off-pump coronary artery bypass grafting (OPCAB) using exclusively three in situ arterial conduits: bilateral internal thoracic arteries (BITA) and the right gastroepiploic artery (rGEA), all harvested using a skeletonization technique.
How long should a patient wait for surgery after NSTEMI?
This study explores the impact of the time elapsed between coronary angiography and coronary artery bypass grafting (CABG) in patients presenting with non–ST-segment elevation myocardial infarction (NSTEMI).
Dubious benefits of dual antiplatelet therapy after coronary surgery: new evidence in 2201 patients
A prospective randomized study including more than 2000 patients compared the outcomes of single antiplatelet therapy with aspirin versus dual antiplatelet therapy with aspirin and ticagrelor during the year following coronary artery bypass grafting (CABG) performed for acute coronary syndrome (ACS).
Results of no-touch versus conventionally harvested saphenous vein use in coronary artery bypass surgery: a meta-analysis of randomized clinical trials
This article presents a meta-analysis of randomized trials comparing the no-touch technique with the conventional harvesting technique, all including imaging-based follow-up over a mean period of 3.7 years, aiming to address the apparent discordance in the current literature.
I, robot, in coronary surgery
Initial experience from a chinese center in minimally invasive multivessel coronary revascularization combining robotic assistance and a minimally invasive surgical approach
Clinical practice guidelines for heroic surgery: consensus on mechanical complications of myocardial infarction
AATS consensus document on the surgical management of mechanical complications following acute myocardial infarction.